Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to Oncology Hematology Associates of Saginaw Valley PC · Saginaw, Michigan
Answer a few short questions to share with the research team.
0 of 3 answered